Linda Lebon

Consigliere Generale presso OSE IMMUNOTHERAPEUTICS

58 anni

Health Technology

Consumer Services

Profilo

Linda Lebon is currently the Chief Regulatory Officer at OSE Immunotherapeutics SA since 2021.
Prior to this, she worked as the Chief Regulatory Officer at Bone Therapeutics SA from 2018 to 2021.
Before that, she held the position of Vice President-Regulatory Affairs at argenx SE and Director-Regulatory Affairs at iTeos Therapeutics SA. Ms. Lebon holds an MBA from École des Hautes Études Commerciales de Paris and a graduate degree from Centre Hospitalier Universitaire de Liege.

Posizioni attive di Linda Lebon

Società	Posizione	Inizio
OSE IMMUNOTHERAPEUTICS	Consigliere Generale	20/12/2021

Tutte le posizioni attive di Linda Lebon

Precedenti posizioni note di Linda Lebon

Società	Posizione	Fine
BIOSENIC SA	Consigliere Generale	01/09/2021
ARGENX SE	Consigliere Generale	-
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.	Consigliere Generale	-

Vedi nel dettaglio l'esperienza di Linda Lebon

Formazione di Linda Lebon

École des Hautes Études Commerciales de Paris	Masters Business Admin
Centre Hospitalier Universitaire de Liege	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Linda Lebon

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ARGENX SE	Health Technology
OSE IMMUNOTHERAPEUTICS	Health Technology

Aziende private	2
Bone Therapeutics SA Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium.	Health Technology
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.	Health Technology